Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.

MLA

Bagaglio, Sabrina, et al. “Reversion of Naturally Occurring High-Level Resistance Mutations to NS3 Protease Inhibitors in Two Treatment-Naive Individuals Infected with Hepatitis C Virus.” The Journal of Antimicrobial Chemotherapy, vol. 68, no. 6, June 2013, pp. 1448–50. EBSCOhost, https://doi.org/10.1093/jac/dkt019.

APA

Bagaglio, S., Messina, E., Uberti-Foppa, C., Merli, M., Torre, L. D., Lazzarin, A., Hasson, H., & Morsica, G. (2013). Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus. The Journal of Antimicrobial Chemotherapy, 68(6), 1448–1450. https://doi.org/10.1093/jac/dkt019

Chicago

Bagaglio, Sabrina, Emanuela Messina, Caterina Uberti-Foppa, Marco Merli, Liviana Della Torre, Adriano Lazzarin, Hamid Hasson, and Giulia Morsica. 2013. “Reversion of Naturally Occurring High-Level Resistance Mutations to NS3 Protease Inhibitors in Two Treatment-Naive Individuals Infected with Hepatitis C Virus.” The Journal of Antimicrobial Chemotherapy 68 (6): 1448–50. doi:10.1093/jac/dkt019.